| Stefanutti C, Vivenzio A, Di Giacomo S, et al.
Immunoadsorption apheresis and immunosuppressive drug therapy in the treatment of complicated HCV-related cryoglobulinemia. [JOURNAL ARTICLE]
J Clin Apher 2009 Nov 19.
Abstract | Full Citation | | Maruyama T, Hashimoto T, Suzuki T, et al.
[A case of primary testicular malignant lymphoma associated with contralateral testicural recurrence after a nine-year interval: a case report.] [JOURNAL ARTICLE]
Hinyokika Kiyo 2009 Oct; 55(10):639-643.
Abstract | Full Citation | | Ishii K, Urase F, Nagare Y, et al.
VNCOP-B plus rituximab therapy in elderly patients with aggressive B-cell non-Hodgkin lymphoma: A multicenter experience. [JOURNAL ARTICLE]
Arch Gerontol Geriatr 2009 Nov 17.
Abstract | Full Citation | | Kasamon YL, Luznik L, Leffell MS, et al.
Nonmyeloablative HLA-Haploidentical BMT with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome. [JOURNAL ARTICLE]
Biol Blood Marrow Transplant 2009 Nov 16.
Abstract | Full Citation | | Oshida K, Iwanaga E, Miyamoto K, et al.
Comet assay in murine bone-marrow cell line (FDC-P2). [JOURNAL ARTICLE]
Toxicol In Vitro 2009 Nov 16.
Abstract | Full Citation | | Saha M, Powell AM, Bhogal B, et al.
Pulsed Intravenous Cyclophosphamide and Methylprednisolone Therapy in Refractory Pemphigus. [JOURNAL ARTICLE]
Br J Dermatol 2009 Nov 18.
Abstract | Full Citation | | Mangano K, Nicoletti A, Patti F, et al.
Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis. [JOURNAL ARTICLE]
Clin Exp Immunol 2009 Nov 18.
Abstract | Full Citation | | Andersen RF, Rubak S, Jespersen B, et al.
Early high-dose immunosuppression in Henoch-Schönlein nephrotic syndrome may improve outcome. [JOURNAL ARTICLE]
Scand J Urol Nephrol 2009; 43(5):409-415.
Abstract | Full Citation | Find Related Articles | | Bambury R, Gallagher F, Dodd JD, et al.
Primary cardiac lymphoma: diagnostic tools and treatment challenges. [JOURNAL ARTICLE]
Ir J Med Sci 2009 Nov 17.
Abstract | Full Citation | | Kim YK, Sohn SK, Lee JH, et al.
Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study. [JOURNAL ARTICLE]
Ann Hematol 2009 Nov 18.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
